BLACK DIAMOND THERAPEUTICS Trademark

Trademark Overview

On Friday, August 2, 2019, a trademark application was filed for BLACK DIAMOND THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the BLACK DIAMOND THERAPEUTICS trademark a serial number of 88564765. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Black Diamond Therapeutics, Inc.. The BLACK DIAMOND THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services in connection with identifying genes and biomarkers relevant for cancer; Pharmaceutical research and development services; research and development services in the field of diagnostic tools and tests for identifying patients with genetic mutations or biomarkers relevant to oncology treatment

General Information

Serial Number88564765
Word MarkBLACK DIAMOND THERAPEUTICS
Filing DateFriday, August 2, 2019
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6198088
Registration DateTuesday, November 17, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Description of MarkThe mark consists of a diamond-shaped design which is split in its upper portion. To the right of the design, and separately one above each other, are the terms "BLACK, DIAMOND" and "THERAPEUTICS", all in upper case capital letters.
Goods and ServicesPharmaceutical research services in connection with identifying genes and biomarkers relevant for cancer; Pharmaceutical research and development services; research and development services in the field of diagnostic tools and tests for identifying patients with genetic mutations or biomarkers relevant to oncology treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2019
Primary Code042
First Use Anywhere DateTuesday, January 2, 2018
First Use In Commerce DateTuesday, January 2, 2018

Trademark Owner History

Party NameBlack Diamond Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameBlack Diamond Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameBlack Diamond Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, August 6, 2019NEW APPLICATION ENTERED
Thursday, August 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 31, 2019ASSIGNED TO EXAMINER
Friday, November 8, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, November 8, 2019EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, November 27, 2019NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 1, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 5, 2020ASSIGNED TO LIE
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 19, 2020FINAL REFUSAL WRITTEN
Friday, June 19, 2020FINAL REFUSAL E-MAILED
Friday, June 19, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 29, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 29, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, July 29, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 29, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, July 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, November 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 17, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics diamond black research services relevant pharmaceutical biomarkers development identifying genetic patients mutations